Skip to main content
Caplight Logo









IntoCNS

IntoCNS

Private
Yongin-siHealthcare & Life Scienceshttps://intocns.com/en

Last Round

Strategic

Mar 1, 2025

Momentum

Top 50%

of companies Caplight tracks

Company Overview

IntoCNS operates in Healthcare & Life Sciences and is based in Yongin-si. Its latest recorded funding round was a Strategic round in March 2025.

IntoCNS is a veterinary healthcare technology company that develops electronic medical record (EMR) solutions, AI-driven clinical tools, and integrated management platforms for animal hospitals.

Sector

Healthcare & Life Sciences

Verticals

EHR & EMR, Medical Devices, Vertical SaaS, Health IoT, Medical Imaging

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting, Hardware + Subscription

AI Layer

Application

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

IntoCNS Comparables

Compare IntoCNS with similar companies based on industry and business-model similarity.

IntoCNS comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
IAMDT
86%
Vetching
84%
Rayence Co. Ltd
84%
Book a demo to see all comparables

For institutional investors. Book with your work email.

IntoCNS Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
StrategicMar 1, 2025
Early FundingJul 1, 2015
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Key People

Founding team and executive leadership

허성호

대표이사(CEO)

Executive Team

노종옥

COO

Executive Team

Heeil Shin

CPO

Executive Team

For institutional investors. Book with your work email.

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 26, 2026

    Monthly visitors increased 30% MoM, reaching 12K.

  • Apr 21, 2026

    Monthly visitors increased 39% MoM.

Book a demo to see all signals

For institutional investors. Book with your work email.

IntoCNS Filings

Explore SEC and related filing metadata, where available.

IntoCNS filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about IntoCNS's valuation, stock price, and market status.

Is IntoCNS a public or private company?

IntoCNS is a private company.

What is the current stock price of IntoCNS?

IntoCNS is a private company, so its shares have no public market price. Caplight tracks IntoCNS's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is IntoCNS worth (valuation)?

Valuation information for IntoCNS is not publicly available.

Can I buy IntoCNS stock?

IntoCNS shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was IntoCNS's last funding round?

IntoCNS's most recent funding round was Strategic on March 1, 2025.

Who are the main investors in IntoCNS?

Investor information for IntoCNS is not publicly disclosed.

Will IntoCNS IPO soon?

No public IPO plans have been announced for IntoCNS.

How can I track IntoCNS secondary market activity?

Caplight tracks bids, offers, and trades in IntoCNS's shares on secondary markets.

Firmographic Details

HeadquartersYongin-si
Employee Range22
Year Founded2007
Last FundingMar 1, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?